Extracellular vesicle long non-coding RNA-mediated crosstalk in the tumor microenvironment: Tiny molecules, huge

Wei-Long Zhang1, Yan Liu2, Jian Jiang3

  • 1State Key Laboratory of Oral Diseases and National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China.

Cancer Science
|May 22, 2020
PubMed

Insights

Extracellular vesicles carrying long non-coding RNAs (lncRNAs) mediate communication within the tumor microenvironment, influencing cancer progression and treatment response. Understanding this crosstalk is key for developing novel cancer diagnostics and therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • The tumor microenvironment is a complex ecosystem where cellular crosstalk influences cancer progression and treatment outcomes.
  • Extracellular vesicles (EVs) are key mediators of intercellular communication, transferring bioactive molecules like long non-coding RNAs (lncRNAs) between cells.
  • Dysregulation of EV-lncRNAs has been implicated in remodeling the tumor microenvironment and promoting aggressive cancer phenotypes.

Purpose of the Study:

  • To review the role of EV-lncRNAs in mediating crosstalk between tumor and stromal cells within the tumor microenvironment.
  • To explore the mechanisms of selective lncRNA sorting into EVs.
  • To highlight the potential clinical applications of EV-lncRNAs in cancer diagnosis and treatment.

Main Methods:

  • Literature review focusing on extracellular vesicle biology and lncRNA research in cancer.
  • Analysis of studies investigating intercellular communication within the tumor microenvironment.
  • Synthesis of current knowledge on EV biogenesis, cargo sorting, and functional impact.

Main Results:

  • EVs, including exosomes, microvesicles, and apoptotic bodies, facilitate the transfer of lncRNAs between cancer cells and other cells in the tumor microenvironment.
  • EV-lncRNAs can reprogram recipient cells, promoting tumor growth, metastasis, and resistance to chemotherapy.
  • Specific mechanisms governing the selective packaging of lncRNAs into EVs are being elucidated.

Conclusions:

  • EV-lncRNA-mediated crosstalk is a critical factor in cancer development and progression.
  • Targeting EV-lncRNA pathways offers promising avenues for innovative cancer therapies.
  • Further research into EV-lncRNA sorting mechanisms could lead to improved diagnostic biomarkers and therapeutic strategies.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.6K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.3K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.6K